Literature DB >> 12538814

Neuroprotective effects of L-arginine administration after cortical impact injury in rats: dose response and time window.

Leela Cherian1, Geeta Chacko, Clay Goodman, Claudia S Robertson.   

Abstract

Administration of L-arginine has been shown to increase cerebral blood flow and reduce neurological damage after experimental traumatic brain injury. The purpose of this study was to examine the optimal dose and time window for these neuroprotective effects. In a dose response experiment, doses of L-arginine ranging from 37.5 to 600 mg/kg were administered 5 min after a 5-m/s, 3-mm, controlled cortical impact in rats. The amount of brain injury found at 2 weeks after injury, both at the contusion site and in the ipsilateral hippocampus, were inversely related to the dose of L-arginine administered. Both 300- and 600-mg/kg doses of L-arginine significantly reduced contusion volume. The 300-mg/kg dose significantly increased the neuron density in the CA1 region of the hippocampus. Physiological effects of L-arginine were also dose-related. The greatest reduction in intracranial pressure occurred with the 300-mg/kg dose of L-arginine. Doses up to 300 mg/kg were well tolerated, but the 600-mg/kg dose resulted in transient hypotension. In another experiment, 300 mg/kg L-arginine was administered at times varying from 5 min to 48 h after injury. Contusion volume was significantly reduced when the L-arginine was given at 5 min and 1 h after injury. The protective effect was less when the same dose was given at the later times, but there was no evidence of an adverse effect even when the L-arginine was administered 48 h after injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12538814     DOI: 10.1124/jpet.102.043430

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  Combining glial cell line-derived neurotrophic factor gene delivery (AdGDNF) with L-arginine decreases contusion size but not behavioral deficits after traumatic brain injury.

Authors:  M L Degeorge; D Marlowe; E Werner; K E Soderstrom; M Stock; A Mueller; M C Bohn; D A Kozlowski
Journal:  Brain Res       Date:  2011-06-02       Impact factor: 3.252

2.  Arginase overexpression in neurons and its effect on traumatic brain injury.

Authors:  Simran Madan; Bettina Kron; Zixue Jin; George Al Shamy; Philippe M Campeau; Qin Sun; Shan Chen; Leela Cherian; Yuqing Chen; Elda Munivez; Ming-Ming Jiang; Claudia Robertson; Clay Goodman; Rajiv R Ratan; Brendan Lee
Journal:  Mol Genet Metab       Date:  2018-07-25       Impact factor: 4.797

3.  Variants of the endothelial nitric oxide gene and cerebral blood flow after severe traumatic brain injury.

Authors:  Claudia S Robertson; Shankar P Gopinath; Alex B Valadka; Mai Van; Paul R Swank; J Clay Goodman
Journal:  J Neurotrauma       Date:  2011-05-04       Impact factor: 5.269

4.  Vascular neural network phenotypic transformation after traumatic injury: potential role in long-term sequelae.

Authors:  J Badaut; G J Bix
Journal:  Transl Stroke Res       Date:  2013-11-29       Impact factor: 6.829

Review 5.  Drug targets for traumatic brain injury from poly(ADP-ribose)polymerase pathway modulation.

Authors:  Valerie C Besson
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

6.  Intrathecal and systemic alterations of L-arginine metabolism in patients after intracerebral hemorrhage.

Authors:  Marius M Mader; Rainer Böger; Daniel Appel; Edzard Schwedhelm; Munif Haddad; Malte Mohme; Katrin Lamszus; Manfred Westphal; Patrick Czorlich; Juliane Hannemann
Journal:  J Cereb Blood Flow Metab       Date:  2021-01-18       Impact factor: 6.200

7.  Effects of L-arginine pre-treatment in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's diseases in Balb/c mice.

Authors:  Javad Hami; Mehran Hosseini; Sekineh Shahi; Nassim Lotfi; Abolfazl Talebi; Mohammad Afshar
Journal:  Iran J Neurol       Date:  2015-10-07

8.  Beneficial effects of L-arginine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neuronal degeneration in substantia nigra of Balb/c mice.

Authors:  Javad Hami; Mehran Hosseini; Saeed Vafaei Nezhad; Sekineh Shahi; Nassim Lotfi; Hossein Ehsani; Akram Sadeghi
Journal:  Adv Biomed Res       Date:  2016-08-30

Review 9.  Suitability of Banana and Plantain Fruits in Modulating Neurodegenerative Diseases: Implicating the In Vitro and In Vivo Evidence from Neuroactive Narratives of Constituent Biomolecules.

Authors:  Barnabas Oluwatomide Oyeyinka; Anthony Jide Afolayan
Journal:  Foods       Date:  2022-07-29

10.  Endogenous nitric-oxide synthase inhibitor ADMA after acute brain injury.

Authors:  Carla S Jung; Christian Wispel; Klaus Zweckberger; Christopher Beynon; Daniel Hertle; Oliver W Sakowitz; Andreas W Unterberg
Journal:  Int J Mol Sci       Date:  2014-03-06       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.